NASDAQ:RVPH

Reviva Pharmaceuticals Holdings Stock Earnings Reports

etoro logo Buy RVPH
*Your capital is at risk
$0.660
+0.0500 (+8.20%)
At Close: Jun 22, 2026

Reviva Pharmaceuticals Holdings Earnings Calls

Mar 31, 2026
-$0.460 (38.67%)
Release date May 14, 2026
EPS estimate -$0.750
EPS actual -$0.460
EPS Surprise 38.67%
Revenue estimate -
Revenue actual -
Dec 31, 2025
$0.720 (166.67%)
Release date Mar 30, 2026
EPS estimate -$1.08
EPS actual $0.720
EPS Surprise 166.67%
Revenue estimate -
Revenue actual -
Sep 30, 2025
-$0.0600 (45.45%)
Release date Nov 13, 2025
EPS estimate -$0.110
EPS actual -$0.0600
EPS Surprise 45.45%
Revenue estimate -
Revenue actual -
Jun 30, 2025
-$0.120 (20.00%)
Release date Aug 14, 2025
EPS estimate -$0.150
EPS actual -$0.120
EPS Surprise 20.00%
Revenue estimate -
Revenue actual -

Last 4 Quarters for Reviva Pharmaceuticals Holdings

Below you can see how RVPH performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Jun 30, 2025 Beat
Release date Aug 14, 2025
Price on release $9.32
EPS estimate -$0.150
EPS actual -$0.120
EPS surprise 20.00%
Date Price
Aug 08, 2025 $8.14
Aug 11, 2025 $8.95
Aug 12, 2025 $9.20
Aug 13, 2025 $9.20
Aug 14, 2025 $9.32
Aug 15, 2025 $10.80
Aug 18, 2025 $10.38
Aug 19, 2025 $10.68
Aug 20, 2025 $10.38
4 days before 14.52%
4 days after 11.37%
On release day 15.83%
Change in period 27.54%
Sep 30, 2025 Beat
Release date Nov 13, 2025
Price on release $10.82
EPS estimate -$0.110
EPS actual -$0.0600
EPS surprise 45.45%
Date Price
Nov 07, 2025 $10.08
Nov 10, 2025 $11.00
Nov 11, 2025 $11.22
Nov 12, 2025 $11.58
Nov 13, 2025 $10.82
Nov 14, 2025 $10.04
Nov 17, 2025 $9.66
Nov 18, 2025 $10.63
Nov 19, 2025 $9.96
4 days before 7.32%
4 days after -7.95%
On release day -7.19%
Change in period -1.21%
Dec 31, 2025 Beat
Release date Mar 30, 2026
Price on release $0.660
EPS estimate -$1.08
EPS actual $0.720
EPS surprise 166.67%
Date Price
Mar 24, 2026 $0.83
Mar 25, 2026 $0.83
Mar 26, 2026 $0.784
Mar 27, 2026 $0.742
Mar 30, 2026 $0.660
Mar 31, 2026 $0.730
Apr 01, 2026 $0.81
Apr 02, 2026 $0.720
Apr 06, 2026 $0.712
4 days before -20.19%
4 days after 7.88%
On release day 10.56%
Change in period -13.91%
Mar 31, 2026 Beat
Release date May 14, 2026
Price on release $0.352
EPS estimate -$0.750
EPS actual -$0.460
EPS surprise 38.67%
Date Price
May 08, 2026 $0.86
May 11, 2026 $0.795
May 12, 2026 $0.795
May 13, 2026 $0.352
May 14, 2026 $0.352
May 15, 2026 $0.352
May 18, 2026 $0.403
May 19, 2026 $0.405
May 20, 2026 $0.391
4 days before -58.87%
4 days after 11.08%
On release day 0%
Change in period -54.31%

Reviva Pharmaceuticals Holdings Earnings History

Earnings Calendar

FAQ

When is the earnings report for RVPH?
Reviva Pharmaceuticals Holdings, Inc. (RVPH) has scheduled its earnings report for Aug 13, 2026 after the markets close.

What is the RVPH price-to-earnings (P/E) ratio?
RVPH P/E ratio as of Jun 22, 2026 (TTM) is -0.258.

What is the RVPH EPS forecast?
The forecasted EPS (Earnings Per Share) for Reviva Pharmaceuticals Holdings, Inc. (RVPH) for the first fiscal quarter 2026 is -$0.360.

What are Reviva Pharmaceuticals Holdings, Inc.'s retained earnings?
On its balance sheet, Reviva Pharmaceuticals Holdings, Inc. reported retained earnings of $0 for the latest quarter ending Mar 31, 2026.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE